News
MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...
Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.
Stockhead on MSN16h
Neurizon’s ALS drug shows safety and extended survival in open-label extension study
Neurizon Therapeutics has reported positive topline results from an open-label extension study of its lead candidate NUZ-001 ...
Summary: A new study has uncovered why some motor neurons resist degeneration in ALS while others succumb. Researchers found ...
TipRanks on MSN7h
NeuroSense Reports Long-Term Safety of PrimeC in ALS Study
The latest update is out from Neurosense Therapeutics Ltd. ( ($NRSN) ). As of August 20, 2025, NeuroSense Therapeutics Ltd. reported that ...
The onset of motor neurone disease (MND) left Sarah without a voice and the use of her hands at the age of 34. It was within ...
ProSpec-Tany TechnoGene Ltd. (prospecbio), an internationally recognized manufacturer of recombinant proteins, today highlighted the groundbreaking p ...
News-Medical.Net on MSN19h
Researchers gain better understanding of how nerve cells can be protected against ALS
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...
Having lived with an ALS diagnosis since 2018, Kate Nycz can tell you firsthand what it's like to slowly lose motor function for basic tasks. "My arm can get to maybe 90 degrees, but then it fatigues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback